Pharmakon Advisors
North America, New York, United States, New York
Description
Pharmakon Advisors is a New York-based investment company that offers financing solutions to commercial stage, biotechnology companies.
Investor Profile
Pharmakon Advisors has made 17 investments, with 3 in the past 12 months and 59% as lead.
Stage Focus
- Post Ipo Debt (82%)
- Post Ipo Equity (6%)
- Series A (6%)
- Debt Financing (6%)
Country Focus
- United States (94%)
- Norway (6%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Biopharma
- Life Science
- Oncology
- Medical Device
- Clinical Trials
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.